IBDEI0A8 ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13573,1,2,0)
 ;;=2^POLYARTERITIS NODOSA
 ;;^UTILITY(U,$J,358.3,13573,2)
 ;;=^91874
 ;;^UTILITY(U,$J,358.3,13574,0)
 ;;=710.4^^88^800^14
 ;;^UTILITY(U,$J,358.3,13574,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13574,1,1,0)
 ;;=1^710.4
 ;;^UTILITY(U,$J,358.3,13574,1,2,0)
 ;;=2^POLYMYOSITIS
 ;;^UTILITY(U,$J,358.3,13574,2)
 ;;=^186822
 ;;^UTILITY(U,$J,358.3,13575,0)
 ;;=452.^^88^800^15
 ;;^UTILITY(U,$J,358.3,13575,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13575,1,1,0)
 ;;=1^452.
 ;;^UTILITY(U,$J,358.3,13575,1,2,0)
 ;;=2^PORTAL VEIN THROMBOSIS
 ;;^UTILITY(U,$J,358.3,13575,2)
 ;;=^269815
 ;;^UTILITY(U,$J,358.3,13576,0)
 ;;=714.2^^88^800^16
 ;;^UTILITY(U,$J,358.3,13576,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13576,1,1,0)
 ;;=1^714.2
 ;;^UTILITY(U,$J,358.3,13576,1,2,0)
 ;;=2^RHEUMATOID ARTHRITIS,SYSTEMIC
 ;;^UTILITY(U,$J,358.3,13576,2)
 ;;=^272111
 ;;^UTILITY(U,$J,358.3,13577,0)
 ;;=135.^^88^800^17
 ;;^UTILITY(U,$J,358.3,13577,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13577,1,1,0)
 ;;=1^135.
 ;;^UTILITY(U,$J,358.3,13577,1,2,0)
 ;;=2^SARCOIDOSIS
 ;;^UTILITY(U,$J,358.3,13577,2)
 ;;=^107916
 ;;^UTILITY(U,$J,358.3,13578,0)
 ;;=710.0^^88^800^18
 ;;^UTILITY(U,$J,358.3,13578,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13578,1,1,0)
 ;;=1^710.0
 ;;^UTILITY(U,$J,358.3,13578,1,2,0)
 ;;=2^SYST LUPUS ERYTHEMATOSIS
 ;;^UTILITY(U,$J,358.3,13578,2)
 ;;=^72159
 ;;^UTILITY(U,$J,358.3,13579,0)
 ;;=710.1^^88^800^19
 ;;^UTILITY(U,$J,358.3,13579,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13579,1,1,0)
 ;;=1^710.1
 ;;^UTILITY(U,$J,358.3,13579,1,2,0)
 ;;=2^SYSTEMIC SCLEROSIS
 ;;^UTILITY(U,$J,358.3,13579,2)
 ;;=^108590
 ;;^UTILITY(U,$J,358.3,13580,0)
 ;;=446.7^^88^800^20
 ;;^UTILITY(U,$J,358.3,13580,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13580,1,1,0)
 ;;=1^446.7
 ;;^UTILITY(U,$J,358.3,13580,1,2,0)
 ;;=2^TAKAYASU'S DISEASE
 ;;^UTILITY(U,$J,358.3,13580,2)
 ;;=^117141
 ;;^UTILITY(U,$J,358.3,13581,0)
 ;;=446.6^^88^800^21
 ;;^UTILITY(U,$J,358.3,13581,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13581,1,1,0)
 ;;=1^446.6
 ;;^UTILITY(U,$J,358.3,13581,1,2,0)
 ;;=2^THROMBOT MICROANGIOPATHY
 ;;^UTILITY(U,$J,358.3,13581,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,13582,0)
 ;;=446.4^^88^800^22
 ;;^UTILITY(U,$J,358.3,13582,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13582,1,1,0)
 ;;=1^446.4
 ;;^UTILITY(U,$J,358.3,13582,1,2,0)
 ;;=2^WEGENER'S GRANULOMATOSIS
 ;;^UTILITY(U,$J,358.3,13582,2)
 ;;=^127623
 ;;^UTILITY(U,$J,358.3,13583,0)
 ;;=444.9^^88^800^9
 ;;^UTILITY(U,$J,358.3,13583,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13583,1,1,0)
 ;;=1^444.9
 ;;^UTILITY(U,$J,358.3,13583,1,2,0)
 ;;=2^OTH ARTERIAL EMB/THROMBOSIS
 ;;^UTILITY(U,$J,358.3,13583,2)
 ;;=^39452
 ;;^UTILITY(U,$J,358.3,13584,0)
 ;;=710.9^^88^800^10
 ;;^UTILITY(U,$J,358.3,13584,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13584,1,1,0)
 ;;=1^710.9
 ;;^UTILITY(U,$J,358.3,13584,1,2,0)
 ;;=2^OTH CONNECTIVE TISSUE DISEASE
 ;;^UTILITY(U,$J,358.3,13584,2)
 ;;=^123811
 ;;^UTILITY(U,$J,358.3,13585,0)
 ;;=453.9^^88^800^11
 ;;^UTILITY(U,$J,358.3,13585,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13585,1,1,0)
 ;;=1^453.9
 ;;^UTILITY(U,$J,358.3,13585,1,2,0)
 ;;=2^OTH VENOUS EMB/THROMBOSIS
 ;;^UTILITY(U,$J,358.3,13585,2)
 ;;=^39455
 ;;^UTILITY(U,$J,358.3,13586,0)
 ;;=441.00^^88^800^1
 ;;^UTILITY(U,$J,358.3,13586,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13586,1,1,0)
 ;;=1^441.00
 ;;^UTILITY(U,$J,358.3,13586,1,2,0)
 ;;=2^ANEURYSM,AORTIC W/ DISSECTION
 ;;^UTILITY(U,$J,358.3,13586,2)
 ;;=^35660
 ;;^UTILITY(U,$J,358.3,13587,0)
 ;;=042.^^88^801^1
 ;;^UTILITY(U,$J,358.3,13587,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13587,1,1,0)
 ;;=1^042.
 ;;^UTILITY(U,$J,358.3,13587,1,2,0)
 ;;=2^AIDS OR HIV INFECTION
 ;;^UTILITY(U,$J,358.3,13587,2)
 ;;=^266500
 ;;^UTILITY(U,$J,358.3,13588,0)
 ;;=540.9^^88^801^2
 ;;^UTILITY(U,$J,358.3,13588,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13588,1,1,0)
 ;;=1^540.9
 ;;^UTILITY(U,$J,358.3,13588,1,2,0)
 ;;=2^APPENDICITIS
 ;;^UTILITY(U,$J,358.3,13588,2)
 ;;=^270195
 ;;^UTILITY(U,$J,358.3,13589,0)
 ;;=682.9^^88^801^3
 ;;^UTILITY(U,$J,358.3,13589,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13589,1,1,0)
 ;;=1^682.9
 ;;^UTILITY(U,$J,358.3,13589,1,2,0)
 ;;=2^CELLULITIS AND ABSCESS
 ;;^UTILITY(U,$J,358.3,13589,2)
 ;;=^21160
 ;;^UTILITY(U,$J,358.3,13590,0)
 ;;=576.1^^88^801^4
 ;;^UTILITY(U,$J,358.3,13590,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13590,1,1,0)
 ;;=1^576.1
 ;;^UTILITY(U,$J,358.3,13590,1,2,0)
 ;;=2^CHOLANGITIS
 ;;^UTILITY(U,$J,358.3,13590,2)
 ;;=^23291
 ;;^UTILITY(U,$J,358.3,13591,0)
 ;;=574.70^^88^801^5
 ;;^UTILITY(U,$J,358.3,13591,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13591,1,1,0)
 ;;=1^574.70
 ;;^UTILITY(U,$J,358.3,13591,1,2,0)
 ;;=2^CHOLECYSTITIS
 ;;^UTILITY(U,$J,358.3,13591,2)
 ;;=^304314
 ;;^UTILITY(U,$J,358.3,13592,0)
 ;;=571.5^^88^801^6
 ;;^UTILITY(U,$J,358.3,13592,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13592,1,1,0)
 ;;=1^571.5
 ;;^UTILITY(U,$J,358.3,13592,1,2,0)
 ;;=2^CIRRHOSIS,NON-ALCOHOLIC
 ;;^UTILITY(U,$J,358.3,13592,2)
 ;;=^24731
 ;;^UTILITY(U,$J,358.3,13593,0)
 ;;=323.9^^88^801^7
 ;;^UTILITY(U,$J,358.3,13593,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13593,1,1,0)
 ;;=1^323.9
 ;;^UTILITY(U,$J,358.3,13593,1,2,0)
 ;;=2^ENCEPHALITIS/MYELITIS
 ;;^UTILITY(U,$J,358.3,13593,2)
 ;;=^334231
 ;;^UTILITY(U,$J,358.3,13594,0)
 ;;=421.9^^88^801^8
 ;;^UTILITY(U,$J,358.3,13594,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13594,1,1,0)
 ;;=1^421.9
 ;;^UTILITY(U,$J,358.3,13594,1,2,0)
 ;;=2^ENDOCARDITIS
 ;;^UTILITY(U,$J,358.3,13594,2)
 ;;=^269701
 ;;^UTILITY(U,$J,358.3,13595,0)
 ;;=422.90^^88^801^9
 ;;^UTILITY(U,$J,358.3,13595,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13595,1,1,0)
 ;;=1^422.90
 ;;^UTILITY(U,$J,358.3,13595,1,2,0)
 ;;=2^MYOCARDITIS
 ;;^UTILITY(U,$J,358.3,13595,2)
 ;;=^269702
 ;;^UTILITY(U,$J,358.3,13596,0)
 ;;=728.86^^88^801^10
 ;;^UTILITY(U,$J,358.3,13596,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13596,1,1,0)
 ;;=1^728.86
 ;;^UTILITY(U,$J,358.3,13596,1,2,0)
 ;;=2^NECROTIZING FASCIITIS
 ;;^UTILITY(U,$J,358.3,13596,2)
 ;;=^303314
 ;;^UTILITY(U,$J,358.3,13597,0)
 ;;=730.20^^88^801^11
 ;;^UTILITY(U,$J,358.3,13597,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13597,1,1,0)
 ;;=1^730.20
 ;;^UTILITY(U,$J,358.3,13597,1,2,0)
 ;;=2^OSTEOMYELITIS NOS-UNSPEC
 ;;^UTILITY(U,$J,358.3,13597,2)
 ;;=^87108
 ;;^UTILITY(U,$J,358.3,13598,0)
 ;;=420.90^^88^801^12
 ;;^UTILITY(U,$J,358.3,13598,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13598,1,1,0)
 ;;=1^420.90
 ;;^UTILITY(U,$J,358.3,13598,1,2,0)
 ;;=2^PERICARDITIS
 ;;^UTILITY(U,$J,358.3,13598,2)
 ;;=^269692
 ;;^UTILITY(U,$J,358.3,13599,0)
 ;;=481.^^88^801^13
 ;;^UTILITY(U,$J,358.3,13599,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13599,1,1,0)
 ;;=1^481.
 ;;^UTILITY(U,$J,358.3,13599,1,2,0)
 ;;=2^PNEUMONIA,PNEUMOCOCCAL
 ;;^UTILITY(U,$J,358.3,13599,2)
 ;;=^95612
 ;;^UTILITY(U,$J,358.3,13600,0)
 ;;=480.0^^88^801^14
 ;;^UTILITY(U,$J,358.3,13600,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13600,1,1,0)
 ;;=1^480.0
 ;;^UTILITY(U,$J,358.3,13600,1,2,0)
 ;;=2^PNEUMONIA,VIRAL
 ;;^UTILITY(U,$J,358.3,13600,2)
 ;;=^269928
 ;;^UTILITY(U,$J,358.3,13601,0)
 ;;=486.^^88^801^15
 ;;^UTILITY(U,$J,358.3,13601,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13601,1,1,0)
 ;;=1^486.
 ;;^UTILITY(U,$J,358.3,13601,1,2,0)
 ;;=2^PNEUMONIA, ORGANISM NOS
 ;;^UTILITY(U,$J,358.3,13601,2)
 ;;=^95632
 ;;^UTILITY(U,$J,358.3,13602,0)
 ;;=038.9^^88^801^16
 ;;^UTILITY(U,$J,358.3,13602,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13602,1,1,0)
 ;;=1^038.9
 ;;^UTILITY(U,$J,358.3,13602,1,2,0)
 ;;=2^SEPSIS
 ;;^UTILITY(U,$J,358.3,13602,2)
 ;;=^109318
 ;;^UTILITY(U,$J,358.3,13603,0)
 ;;=995.90^^88^801^17
 ;;^UTILITY(U,$J,358.3,13603,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13603,1,1,0)
 ;;=1^995.90
 ;;^UTILITY(U,$J,358.3,13603,1,2,0)
 ;;=2^SYSTEM INFLAM RESPONSE SYNDROM
 ;;^UTILITY(U,$J,358.3,13603,2)
 ;;=^328611
 ;;^UTILITY(U,$J,358.3,13604,0)
 ;;=136.9^^88^801^18
 ;;^UTILITY(U,$J,358.3,13604,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13604,1,1,0)
 ;;=1^136.9
 ;;^UTILITY(U,$J,358.3,13604,1,2,0)
 ;;=2^OTH INFECTIOUS CONDITIONS
 ;;^UTILITY(U,$J,358.3,13604,2)
 ;;=^123934
 ;;^UTILITY(U,$J,358.3,13605,0)
 ;;=99377^^89^802^1^^^^1
 ;;^UTILITY(U,$J,358.3,13605,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13605,1,1,0)
 ;;=1^99377
 ;;^UTILITY(U,$J,358.3,13605,1,2,0)
 ;;=2^Hospice Care Supervision,15-29 min
 ;;^UTILITY(U,$J,358.3,13606,0)
 ;;=99378^^89^802^2^^^^1
 ;;^UTILITY(U,$J,358.3,13606,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13606,1,1,0)
 ;;=1^99378
 ;;^UTILITY(U,$J,358.3,13606,1,2,0)
 ;;=2^Hospice Care Supervision,30 min or more
 ;;^UTILITY(U,$J,358.3,13607,0)
 ;;=G0182^^89^802^12^^^^1
 ;;^UTILITY(U,$J,358.3,13607,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13607,1,1,0)
 ;;=1^G0182
 ;;^UTILITY(U,$J,358.3,13607,1,2,0)
 ;;=2^Hospice Care-Use with each encounter
 ;;^UTILITY(U,$J,358.3,13608,0)
 ;;=99367^^89^803^1^^^^1
 ;;^UTILITY(U,$J,358.3,13608,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13608,1,1,0)
 ;;=1^99367
 ;;^UTILITY(U,$J,358.3,13608,1,2,0)
 ;;=2^ Team Conf w/o Pt by Phys >30min
 ;;^UTILITY(U,$J,358.3,13609,0)
 ;;=99201^^90^804^1
 ;;^UTILITY(U,$J,358.3,13609,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13609,1,1,0)
 ;;=1^BRIEF EXAM
 ;;^UTILITY(U,$J,358.3,13609,1,2,0)
 ;;=2^99201
 ;;^UTILITY(U,$J,358.3,13610,0)
 ;;=99202^^90^804^2
 ;;^UTILITY(U,$J,358.3,13610,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13610,1,1,0)
 ;;=1^LIMITED EXAM
 ;;^UTILITY(U,$J,358.3,13610,1,2,0)
 ;;=2^99202
 ;;^UTILITY(U,$J,358.3,13611,0)
 ;;=99203^^90^804^3
 ;;^UTILITY(U,$J,358.3,13611,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13611,1,1,0)
 ;;=1^INTERMEDIATE EXAM
 ;;^UTILITY(U,$J,358.3,13611,1,2,0)
 ;;=2^99203
 ;;^UTILITY(U,$J,358.3,13612,0)
 ;;=99204^^90^804^4
 ;;^UTILITY(U,$J,358.3,13612,1,0)
 ;;=^358.31IA^2^2
